Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersNo recent work listed

Sophie C. Lodestijn

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5023563715. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. Co-author DOI 10.1002/ijc.34276↗
  2. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2021.109852↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Louis Vermeulen · 2 shared papers, 2021–2023 · strength 0.26
  2. Maarten F. Bijlsma · 2 shared papers, 2021–2023 · strength 0.26
  3. Mark P.G. Dings · 1 shared paper, 2023 · strength 0.14
  4. Izaak Quintus Molenaar · 1 shared paper, 2023 · strength 0.14
  5. Nadia Haj Mohammad · 1 shared paper, 2023 · strength 0.14
  6. Michail Doukas · 1 shared paper, 2023 · strength 0.14
  7. Hanneke W.M. van Laarhoven · 1 shared paper, 2023 · strength 0.14
  8. Ignace H. J. T. de Hingh · 1 shared paper, 2023 · strength 0.14
  9. Bert A. Bonsing · 1 shared paper, 2023 · strength 0.14
  10. Marin Strijker · 1 shared paper, 2023 · strength 0.14
  11. Paul Manoukian · 1 shared paper, 2023 · strength 0.14
  12. Marco J. Bruno · 1 shared paper, 2023 · strength 0.14
  13. Marc G. Besselink · 1 shared paper, 2023 · strength 0.14
  14. Casper H.J. van Eijck · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.